As reported for cholestasis, an elevated BA pool acts as an endogenous ligand for FXR activation, a negative feedback regulator of CYP7A1, to restrict de-novo BA synthesis via a JNK-dependent mechanism.27 The gene discussed is MAPK8; the disease is cholestasis.